Listed pharmaceutical companies showed increase in sales, and they succeeded to hold down selling and administrative expense.

It was analyzed that listed pharmaceutical companies showed increase in sales, and they succeeded to hold down selling and administrative expense. According to audit reports of KOSPI and KOSDAQ listed pharmaceutical companies reported by the Financial Supervisory Service (FSS) in 2013, the companies showed an average of 13% increase in sales and 9% increase in selling and administrative expens...